US FDA Approves Kloxxado™ (naloxone HCl) Nasal Spray 8 mg to Treat Opioid Overdose

Hikma Pharmaceuticals announced, on April 30th 2021, the US Food and Drug Administration (FDA) approval of Kloxxado™ (naloxone HCl) Nasal Spray 8 mg, a new opioid overdose reversal medication. This [...]